Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis

Published:2016-07 Issue: Volume:102 Page:21-32
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Man Dede K.W.,Chow Michael Y.T.,Casettari Luca,Gonzalez-Juarrero Mercedes,Lam Jenny K.W.

Funder

Area of Excellence Scheme of the University Grants Committee, Hong Kong

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference160 articles.

1. Extensively drug-resistant tuberculosis: epidemiology and management;Matteelli;Clin. Epidemiol.,2014

2. Definitions and Reporting Framework for Tuberculosis - 2013 Revision;WHO,2013

3. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran;Velayati;Chest,2009

4. Delamanid: a review of its use in patients with multidrug-resistant tuberculosis;Blair;Drugs,2015

5. New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid;Brigden;Infect. Drug Resist.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases;Acta Pharmaceutica Sinica B;2023-04

2. Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosis;Nucleic Acid Therapeutics;2022-10-01

3. Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment;Pharmaceutical Research;2022-09-19

4. Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application;Pharmaceutics;2022-06-02

5. Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens;Antibiotics;2022-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3